Cyclodiode photocoagulation for refractory glaucoma after penetrating keratoplasty.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Lee, Graham A.
Kirwan, James K.
Bloom, Philip A.
Ficker, Linda A.
Khaw, Peng T.
MetadataShow full item record
AbstractOBJECTIVE: This study analyzes the results of intraocular pressure (IOP) reduction by contact diode cycloablation (cyclodiode) in cases of refractory glaucoma after penetrating keratoplasty. DESIGN: Retrospective noncomparative, interventional case series. PARTICIPANTS: Twenty-eight eyes in 28 patients attending the Moorfields Eye Hospital. INTERVENTION: Cyclodiode (40 applications x 1.5 W x 1.5 seconds over 270-300 degrees ) was used to control the IOP in refractory glaucoma after penetrating keratoplasty. MAIN OUTCOME MEASURES: Postoperative IOP, graft status, visual acuity, and number of antiglaucoma medications were recorded after cyclodiode treatment. RESULTS: Cyclodiode resulted in a reduction of IOP from a median of 33 mmHg (interquartile range [28, 40.5]) to a median of 15 mmHg (interquartile range [12, 20.5]). Most patients had a significant lowering in IOP with a median reduction of 16 mmHg (interquartile range [12, 25]; P < 0.0001). IOPs of 6 to 21 mmHg were achieved in 22 patients (79%). Sixteen patients (57%) required more than one treatment with cyclodiode to control the IOP, with three patients (11%) requiring three treatments and two patients (7%) requiring four treatments. Visual acuity improved (> two Snellen lines of acuity) in three patients (11%) and remained the same (+/- one Snellen line) in 17 patients (61%). The mean number of antiglaucoma medications before cycloablation was 2.6 and was 1.8 after treatment (P < 0.001). Of the 19 patients (68%) with originally clear grafts, three grafts (16%) developed opacification. One patient (4%), with a history of nanophthalmos and recurrent uveal effusion, had delayed hypotony (IOP < 6 mmHg) occurring 46 months after the diode treatment. All patients had at least 6 months follow-up. CONCLUSIONS: These patients have often undergone multiple previous complicated ocular interventions and are often not suitable for filtration surgery. Reduction of IOP with maintenance of visual acuity and a good safety profile was achieved in most patients in this study but may require multiple treatments. We propose cyclodiode as an effective treatment for many patients in the management of refractory glaucoma after penetrating keratoplasty.
CitationOphthalmology, 108(11): 1986-1991
PublisherElsevier Science Direct
CollectionsCentre for Health and Social Care Improvement
- Diode laser transscleral cyclophotocoagulation for the treatment of refractory glaucoma after penetrating keratoplasty.
- Authors: Ocakoglu O, Arslan OS, Kayiran A
- Issue date: 2005 Jul
- Transvitreal endocyclophotocoagulation.
- Authors: Haller JA
- Issue date: 1996
- "Cyclodiode". Trans-scleral diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma.
- Authors: Bloom PA, Tsai JC, Sharma K, Miller MH, Rice NS, Hitchings RA, Khaw PT
- Issue date: 1997 Sep
- Diode laser cyclophotocoagulation: role in the management of refractory pediatric glaucomas.
- Authors: Kirwan JF, Shah P, Khaw PT
- Issue date: 2002 Feb
- Comparison of mitomycin C trabeculectomy, glaucoma drainage device implantation, and laser neodymium:YAG cyclophotocoagulation in the management of intractable glaucoma after penetrating keratoplasty.
- Authors: Ayyala RS, Pieroth L, Vinals AF, Goldstein MH, Schuman JS, Netland PA, Dreyer EB, Cooper ML, Mattox C, Frangie JP, Wu HK, Zurakowski D
- Issue date: 1998 Aug